Ivan Astralaga
Corporate Officer/Principal en C-RAD AB .
Fortuna: 72 618 $ al 30/04/2024
Cargos activos de Ivan Astralaga
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
C-RAD AB | Corporate Officer/Principal | 21/05/2021 | - |
Historial de carrera de Ivan Astralaga
Antiguos cargos conocidos de Ivan Astralaga.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Ventas & Marketing | 01/08/2019 | 01/04/2021 |
Estadísticas
Internacional
Suecia | 2 |
Estados Unidos | 2 |
Operativa
Corporate Officer/Principal | 1 |
Sales & Marketing | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
C-RAD AB | Health Technology |
Empresas privadas | 1 |
---|---|
Mevion Medical Systems, Inc.
Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Mevion Medical Systems, Inc. provides proton therapy systems for cancer centers, clinicians and patients worldwide. Its MEVION S250 Series is designed to deliver proton therapy treatments, optimizing both the outcomes and the economics of proton therapy. Its products include Mevion S250i with hyperscan and Mevion 250mx. The company was founded by Kenneth A. Gall in 2004 and is headquartered in Littleton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ivan Astralaga
- Experiencia